(Date:12/2/2009)...ire/ -- S*BIO Pte Ltd today announced data present...t The American Society of Hematology 51st Annual M...ill be presented on the clinical results from the ...its safety, tolerability and pharmacokinetic/pharm...from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)...eading scientific magazine covering the life scien...lligent” EMCCD camera fourth among the publi... , (PRWEB) December 2, 200...metrics ®, a designer and manufacturer of high...iences, was ranked fourth among The Scientist&rsqu...
(Date:12/1/2009)...re/ -- Reportlinker.com announces that a new marke..., Industrial Enzymes - A Global Market Report ...trial-Enzymes---A-Global-Market-Report.html ,,...w strong players and a host of small suppliers eng...and commoditization characterize the industry. Raz...
(Date:12/1/2009)...e-Asia/ -- Shanghai ChemPartner, as the,flagship s...ntract Research,Organization (CRO), today announce...ast 50 China, ranking 3rd on the list of the faste... is a testament to ChemPartner,s outstanding,three... The results of the 2009 Deloitte Technology Fast ...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3...Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...Board of Directors, unexpectedly passed away on We...ne since 2004 and was chairman since 2005. At the...s Audit Committee, Compensation Committee and Nomi...ur business colleague and friend Tom Waltz brings ...
...all/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX...exceeded the primary statistical endpoint in its m... intravenous administration of REOLYSIN(R) in pati...to the lung. , "The proportion of patients on st...ul responses is highly encouraging," said Dr. Fran...
...n and Patient-Centered Approach Expected to Drive ... 10 Pharmaceutical Companies in Worldwide Sales, ...Strategy Expands Global Reach and Improves R&D...f Bringing New Medicine to Market from, $1.2...ipeline Boasts Unprecedented 59 Molecules in Clini...
Other Biology Technology:Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz 2Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study 2Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study 3Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study 4Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 2Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 3Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 4Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 5Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 6Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 7Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 8Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 9Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 10Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 11Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 12Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 13Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 14Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance 15(Date:12/2/2009)..., Sally Hall, a PhD student at the University of S...ES) at the National Oceanography Centre, Southampt...of king crab, all from the deep sea. , Hall disc...ons of the National Museum of Natural History in W..., she said: "King crabs include some of the larges...
(Date:12/1/2009)...Researchers at the Yerkes National Primate Researc...rated the first transgenic prairie voles, an impor...pair bonding. The future application of this tech... genetic manipulations that will help identify the...lex social behaviors. This advancement may also ha...
(Date:12/1/2009)...Particularly in Alzheimer,s disease, nerve cell de...w therapeutic options may possibly be derived from...m. These findings have been published in the curre...nce . Until only a few years ago, neurogenesis th...d to be impossible in the adult brain. The textboo...
Breaking Biology News(10 mins):King crab family bigger than ever 2Yerkes researchers create first transgenic prairie voles 2New source discovered for the generation of nerve cells in the brain 2Penn study demonstrates new way to boost immune memory 47936 1Penn study demonstrates new way to boost immune memory 47936 2Penn study demonstrates new way to boost immune memory 47936 3WaveSense Reduces Diabetes Testing Cost by 50 25 47934 1WaveSense Reduces Diabetes Testing Cost by 50 25 47934 2Custom Spine Welcomes Randal Clarke as Vice President of Sales 47929 1Custom Spine Welcomes Randal Clarke as Vice President of Sales 47929 2Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Unconjugated from R&D Systems
Donor Equine Serum from Equitech-Bio
Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Biotin Conjugated from R&D Systems
Caspase-8 Inhibitor Z-IETD-FMK from BioVision
Biology Products: